Plant Comparison
Hawthorn vs Hop
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Hawthorn and Hop: they share 4 indicated uses (arthritis / joint pain, inflammation (general), insomnia / sleeplessness, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Hawthorn | Hop | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Insomnia / sleeplessness | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal cardioprotective and antioxidant polyphenols characterised by chemical profiling of leaf, flower and fruit.
Contribute to the vasoactive and antioxidant effects, the basis for extract standardisation.
Alpha- and beta-bitter acids responsible for the characteristic bitterness and much of the sedative, GABA-A-receptor-active and antimicrobial activity.
Xanthohumol has antioxidant activity; 8-prenylnaringenin has notable phytoestrogenic activity, the basis of the mild oestrogenic caution.
Aromatic volatile oil contributing to the characteristic hop aroma.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from digestive action
inferred from anti-inflammatory action
inferred from sedative action
Safety, Cautions & Contraindications
Generally well tolerated. Hawthorn should not replace prescribed cardiac medications without medical supervision. May potentiate the effects of cardiac glycosides (digoxin), antihypertensive drugs, and coronary dilators. Not recommended during pregnancy and breastfeeding due to insufficient safety data. Mild side effects (nausea, dizziness, GI upset) occasionally reported.
Duke (2002) rates hawthorn as +++ — one of the most clinically supported cardiovascular herbs. Clinical evidence (score 2) supports its use for decreasing cardiac output (NYHA functional Stage II heart failure), as recognized by Commission E. Key activities include vasodilation, positive inotropic effects, and antioxidant protection of vascular tissue. Dose: 160–900 mg standardized leaf/flower extract (containing 18.75% oligomeric proanthocyanidins) daily. Duke emphasizes that hawthorn should not replace conventional heart failure therapy, and therapeutic effects may take 4–8 weeks to emerge. Mild interactions with cardiac glycosides (digitalis) are possible (Duke, 2002).
Generally safe at therapeutic doses for short-term use. Hop preparations may enhance the sedative effects of alcohol, benzodiazepines, and other CNS depressants — avoid combination. Not recommended during pregnancy or breastfeeding. May have mild oestrogenic effects due to 8-prenylnaringenin — caution in hormone-sensitive conditions. Fresh hops can cause contact dermatitis in pickers.
Duke (2002) rates hops as +++ and provides clinical evidence (score 2) for sedative activity, consistent with Commission E approval for nervousness, unrest, and sleep disturbances. The primary sedative compound is 2-methyl-3-buten-2-ol, formed from humulone during storage. Duke notes that hop cones have estrogenic activity, explaining occupational menstrual irregularities reported among hop pickers. Dose: 0.5 g dried flower in tea before bed; often combined with valerian. Hops should not be used in depression, as its CNS-depressant effect may worsen depressive symptoms (Duke, 2002).
External Ids
Botanical Description
Small deciduous tree or large shrub, densely thorny, with deeply lobed, glossy leaves (more deeply cut than midland hawthorn). Clusters of small, five-petalled white flowers with a strong, musky scent appear in spring ('May blossom'), followed by small red berries (haws), each containing a single seed (nutlet) - the origin of the species name monogyna.[4]
Vigorous, twining perennial climbing vine with rough, hairy stems and deeply lobed, opposite leaves resembling grape leaves. The plant is dioecious; female plants bear the characteristic papery, cone-like flower clusters ('hops'), covered in yellow, resinous lupulin glands, that are the medicinal and brewing part.[1]
Habitat
One of the commonest hedgerow and scrub trees of Europe, growing in hedgerows, woodland edges, scrub and pasture on a wide range of soils; native to Europe, North Africa and Western Asia.[4]
Grows in hedgerows, woodland edges and damp thickets, climbing over other vegetation; native to Europe, Western Asia and North America, and widely cultivated for brewing.
Harvesting
Flowers are picked as they open in May, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn after the first frosts soften them slightly; all three parts are traditionally combined.[4]
The female flower cones are picked in late summer once mature (when the lupulin glands are fully developed and sticky), then dried quickly to preserve the volatile oils and bitter resins.[1]
Traditional Uses
Common hawthorn shares the same long cardiovascular and calming tradition as midland hawthorn, used across European herbal medicine as a heart tonic for mild circulatory complaints, palpitations and nervous tension, and remains one of the most clinically studied cardiovascular botanicals.[4]
Hop cones have a long European tradition as a calming, sedative herb for nervous tension, restlessness and insomnia, and as a bitter digestive tonic; the sedative reputation, historically noted among hop-pickers who became drowsy from handling the cones, is now linked to GABA-A receptor-active bitter resins.[1]
Preparations
Leaf-and-flower extract standardised to flavonoid or procyanidin content, taken as tablets or capsules; the best-studied clinical form.
Dried flower cones infused in hot water as a herbal tea, 500-1000 mg in 150-200 ml, taken 30-60 minutes before bedtime per the EU herbal monograph. Educational reference only, not a prescription.
Tincture (1:5) of the dried cones, 1-2 ml up to three times daily per the EU herbal monograph. Educational reference only, not a prescription.
Concentrated extract standardised to xanthohumol/humulone content, studied for sleep-enhancing activity via GABA-A receptor modulation.
Dosage
The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.
The EU herbal monograph distinguishes two uses, in adolescents, adults and elderly. To aid sleep - 500-1000 mg of the comminuted flower in 150-200 mL of boiling water as an infusion, 30-60 minutes before bedtime. In mental stress - 500 mg in 150-200 mL as an infusion, up to 4 times daily. A 1:5 tincture at 1-2 mL up to 3 times daily is also listed. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Pairings
Dangerous Lookalikes
Not documented
References & Sources
- Ez-Zahra Amrati, F., Mssillou, I., Boukhira, S., Djiddi Bichara, M. et al (2024) 'Phenolic Composition of Crataegus monogyna Jacq. Extract and Its Anti-Inflammatory, Hepatoprotective, and Antileukemia Effects', Pharmaceuticals (Basel), 17(6), pp. 786. doi:10.3390/ph17060786 Preclinical
https://doi.org/10.3390/ph17060786 - Lis, M., Szczypka, M., Suszko-Pawłowska, A., Sokół-Łętowska, A. et al (2019) 'Hawthorn (Crataegus monogyna) Phenolic Extract Modulates Lymphocyte Subsets and Humoral Immune Response in Mice', Planta Medica, 86(2), pp. 160-168. doi:10.1055/a-1045-5437 Preclinical
https://doi.org/10.1055/a-1045-5437 - Paun, G., Neagu, E., Albu, C., Alecu, A. et al (2024) 'Antioxidant and Antidiabetic Activity of Crataegus monogyna L. and Cornus mas Fruit Extracts', Molecules, 29(15), pp. 3595. doi:10.3390/molecules29153595 Preclinical
https://doi.org/10.3390/molecules29153595 - Nabavi, S.F., Habtemariam, S., Ahmed, T., Sureda, A., Daglia, M. and Sobarzo-Sanchez, E (2015) 'Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications', Nutrients, 7(9), pp. 7708-7728. doi:10.3390/nu7095361 Meta-analysis / review
https://doi.org/10.3390/nu7095361 - Belabdelli, F., Bekhti, N., Piras, A., Benhafsa, F.M., Ilham, M. and Adil, S (2021) 'Chemical composition, antioxidant and antibacterial activity of Crataegus monogyna leaves' extracts', Natural Product Research, 36(12), pp. 3234-3239. doi:10.1080/14786419.2021.1958215 Preclinical
https://doi.org/10.1080/14786419.2021.1958215 - Jalali, A.S., Hasanzadeh, S. and Malekinejad, H (2012) 'Crataegus monogyna aqueous extract ameliorates cyclophosphamide-induced toxicity in rat testis: stereological evidences', Acta Medica Iranica, 50(1), pp. 1-8. Preclinical
https://scholar.google.com/scholar?q=Crataegus%20monogyna%20aqueous%20extract%20ameliorates%20cyclophosphamide-induced%20toxicity%20in%20rat%20testis%3A%20stereological%20evidences - Martin-Garcia, B., Razola-Diaz, M.D.C., Gomez-Caravaca, A.M., Benitez, G. and Verardo, V (2021) 'Setup of an Ultrasonic-Assisted Extraction to Obtain High Phenolic Recovery in Crataegus monogyna Leaves', Molecules, 26(15), pp. 4536. doi:10.3390/molecules26154536 Preclinical
https://doi.org/10.3390/molecules26154536 - Arslan, R., Bektas, N., Bor, Z. and Sener, E (2014) 'Evaluation of the antithrombotic effects of Crataegus monogyna and Crataegus davisii in the carrageenan-induced tail thrombosis model', Pharmaceutical Biology, 53(2), pp. 275-279. doi:10.3109/13880209.2014.914957 Preclinical
https://doi.org/10.3109/13880209.2014.914957 - Edwards, J.E., Brown, P.N., Talent, N., Dickinson, T.A. and Shipley, P.R (2012) 'A review of the chemistry of the genus Crataegus', Phytochemistry, 79, pp. 5-26. doi:10.1016/j.phytochem.2012.04.006 Meta-analysis / review
https://doi.org/10.1016/j.phytochem.2012.04.006 - Jarzycka, A., Lewinska, A., Gancarz, R. and Wilk, K.A (2013) 'Assessment of extracts of Helichrysum arenarium, Crataegus monogyna, Sambucus nigra in photoprotective UVA and UVB; photostability in cosmetic emulsions', Journal of Photochemistry and Photobiology B: Biology, 128, pp. 50-57. doi:10.1016/j.jphotobiol.2013.07.029 Preclinical
https://doi.org/10.1016/j.jphotobiol.2013.07.029 - Lucconi, G., Chlapanidas, T., Martino, E., Gaggeri, R., Perteghella, S. and Rossi, D (2013) 'Formulation of microspheres containing Crataegus monogyna Jacq. extract with free radical scavenging activity', Pharmaceutical Development and Technology, 19(1), pp. 65-72. doi:10.3109/10837450.2012.752387 Preclinical
https://doi.org/10.3109/10837450.2012.752387 - Zorniak, M., Szydlo, B. and Krzeminski, T.F (2017) 'Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences', Journal of Physiology and Pharmacology, 68(4), pp. 521-526. Meta-analysis / review
https://scholar.google.com/scholar?q=Crataegus%20special%20extract%20WS%201442%3A%20up-to-date%20review%20of%20experimental%20and%20clinical%20experiences - European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Lee, H., Chung, S.H., Kwon, D.J., Nam, M.J. et al (2024) 'Sleep-enhancing effect of Hongcheon-hop (Humulus lupulus L.) extract containing xanthohumol and humulone through GABA-A receptor', Journal of Ethnopharmacology, 338(Pt 2), pp. 119019. doi:10.1016/j.jep.2024.119019 Preclinical
https://doi.org/10.1016/j.jep.2024.119019 - Kenda, M., Glavač, N.K., Nagy, M. and Sollner Dolenc, M (2021) 'Herbal Products Used in Menopause and for Gynecological Disorders', Molecules, 26(24), pp. 7421. doi:10.3390/molecules26247421 Traditional / reference
https://doi.org/10.3390/molecules26247421 - Dietz, B.M., Hajirahimkhan, A., Dunlap, T.L. and Bolton, J.L (2016) 'Botanicals and Their Bioactive Phytochemicals for Women's Health', Pharmacological Reviews, 68(4), pp. 1026-1073. doi:10.1124/pr.115.010843 Traditional / reference
https://doi.org/10.1124/pr.115.010843 - Sun, X.L., Xia, T.S., Jiang, Y.P., Wang, N.N., Xu, L.C. and Han, T (2022) 'Humulus lupulus L. extract and its active constituent xanthohumol attenuate oxidative stress and nerve injury induced by iron overload via activating AKT/GSK3beta and Nrf2/NQO1 pathways', Journal of Natural Medicines, 76(4), pp. 801-814. doi:10.1007/s11418-022-01642-1 Preclinical
https://doi.org/10.1007/s11418-022-01642-1 - Karbalaei, N., Sadeghi, N., Nekoeian, A. and Malekzadeh, A (2019) 'Impact of Hydroalcoholic Extract of Humulus Lupulus L. on Sperm Quality, Reproductive Organs and Hormones in Male Rats', Chinese Journal of Integrative Medicine, 25(9), pp. 1-8. doi:10.1007/s11655-019-3025-7 Preclinical
https://doi.org/10.1007/s11655-019-3025-7 - Xia, T.S., Lin, L.Y., Zhang, Q.Y., Jiang, Y.P., Li, C.H. and Liu, X.Y (2019) 'Humulus lupulus L. Extract Prevents Ovariectomy-Induced Osteoporosis in Mice and Regulates Activities of Osteoblasts and Osteoclasts', Chinese Journal of Integrative Medicine, 27(1), pp. 31-38. doi:10.1007/s11655-019-2700-z Preclinical
https://doi.org/10.1007/s11655-019-2700-z - Hurth, Z., Faber, M.L., Gendrisch, F., Holzer, M., Haarhaus, B. and Cawelius, A (2022) 'The Anti-Inflammatory Effect of Humulus lupulus Extract In Vivo Depends on the Galenic System of the Topical Formulation', Pharmaceuticals, 15(3), pp. 350. doi:10.3390/ph15030350 Preclinical
https://doi.org/10.3390/ph15030350 - Caban, M., Chojnacka, K., Owczarek, K., Laskowska, J., Fichna, J. and Podsedek, A (2020) 'Spent hops (Humulus Lupulus L.) extract as modulator of the inflammatory response in lipopolysaccharide stimulated RAW 264.7 macrophages', Journal of Physiology and Pharmacology, 71(1). doi:10.26402/jpp.2020.1.05 Preclinical
https://doi.org/10.26402/jpp.2020.1.05 - Wang, S., Dunlap, T.L., Howell, C.E., Mbachu, O.C., Rue, E.A. and Phansalkar, R (2016) 'Hop (Humulus lupulus L.) Extract and 6-Prenylnaringenin Induce P450 1A1 Catalyzed Estrogen 2-Hydroxylation', Chemical Research in Toxicology, 29(7), pp. 1142-1150. doi:10.1021/acs.chemrestox.6b00112 Preclinical
https://doi.org/10.1021/acs.chemrestox.6b00112 - Kyrou, I., Christou, A., Panagiotakos, D., Stefanaki, C., Skenderi, K. and Katsana, K (2017) 'Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized, placebo-controlled, double-blind, crossover pilot study', Hormones, 16(2), pp. 171-180. doi:10.14310/horm.2002.1738 Randomized trial
https://doi.org/10.14310/horm.2002.1738 - Hege, M., Jung, F., Sellmann, C., Jin, C., Ziegenhardt, D. and Hellerbrand, C (2017) 'An iso-alpha-acid-rich extract from hops (Humulus lupulus) attenuates acute alcohol-induced liver steatosis in mice', Nutrition, 41, pp. 70-77. doi:10.1016/j.nut.2017.07.010 Preclinical
https://doi.org/10.1016/j.nut.2017.07.010 - European Medicines Agency (HMPC) (2014) 'Community herbal monograph on Humulus lupulus L., flos, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-humulus-lupulus-l-flos-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-humulus-lupulus-l-flos-revision-1_en.pdf - Becker, A., Felgentreff, F., Schröder, H., Meier, B. and Brattstrom, A (2014) 'The anxiolytic effects of a Valerian extract is based on valerenic acid', pp. 267. Traditional / reference
https://scholar.google.com/scholar?q=The%20anxiolytic%20effects%20of%20a%20Valerian%20extract%20is%20based%20on%20valerenic%20acid - Koetter, U. and Blumenthal, M (2010) 'Valerian and hops for insomnia: overview of clinical data', pp. 44--50. Traditional / reference
https://scholar.google.com/scholar?q=Valerian%20and%20hops%20for%20insomnia%3A%20overview%20of%20clinical%20data - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Koetter, U., Schrader, E., Kaeufeler, R. and Brattstroem, A (2007) 'A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder', Phytotherapy Research, 21(9), pp. 847-851. doi:10.1002/ptr.2167 Randomized trial
https://doi.org/10.1002/ptr.2167 - Ngan, A. and Conduit, R (2011) 'A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality', Phytotherapy Research, 25(8), pp. 1153-1159. doi:10.1002/ptr.3400 Randomized trial
https://doi.org/10.1002/ptr.3400 - Totally Wild UK 'Hops (Humulus lupulus) Identification Guide'. Available at: https://totallywilduk.co.uk/2022/12/08/hops-humulus-lupulus-identification-guide/ Traditional / reference
https://totallywilduk.co.uk/2022/12/08/hops-humulus-lupulus-identification-guide/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.